Should you buy UNH shares after a decrease by 39% YTD? News ad

Unitedhealth Group NYSE: UNH It is a dominant force in the healthcare sector, a critical industry, which should be included in a diversified long -term investment portfolio. The company’s shares have experienced recent market turbulence, Trading about 39% since the beginning of the year. Since mid -June. Nevertheless, this discounted price from the leader of the industry can be an excellent entry point for investors oriented to the cost that create their portfolios.

Thanks to a reduced price that may not last, Unitedhealt Group provides a timely opportunity for investors who seek to open or diversify positions in the healthcare sector. The company quickly attracts the support of investors from several positive catalysts, including the recent growth of dividends and strategic progress in providing its Latin American activity.

These factors combined with the project of analysts Growth potential about 38%Firmly set the Unitedhealth Group as the highest level for those who are priority for long -term value.

UnitedHealth group: performance, payments and progress

The investment attractiveness of the Unitedhealt Group is based on its extensive operational fund and recent strategic steps. His business is flourishing in two powerful segments. UnitedhealtHCare works as a large US health insurer, serving millions and demonstrating a consistent presence in the market. In the first quarter of 2025, a 2%medical membership was growing in this segment, reaching 50.1 million people. This provides a stable profitable fund for the company.

Addition of this-Optum, Health Services with technology support. Optum serves as a key factor in growth and innovation in its Optum Health, Optum Insight and Optum RX Segments. Its attention on the use of technology and data analysts is designed to increase the efficiency and improve the results of patients in the healthcare ecosystem.

These two business segments are supported by a reliable financial profile of Unitedhead Group, as evidenced by significant annual income in the amount of $ 400.3 billion. The United States in 2024, which grew by about 7.5% compared to the previous year. This financial force, supported by the A+credit rating, underlies the profitability of shareholders.

The company has recently increased its quarterly dividends from $ 2.21 $ 2.21 per share, from June 24, 2025. It gives Annual dividend of 8.84 US dollars And current income 2.85%Noting for 15 years in a row of increase in dividends and emphasizes the consistent commitment of a repayable value to shareholders.

Due to the further optimization of UNITEDEDHELTH GROUP operations, it progresses with the elimination of its Latin American division of BanMedica, in Colombia and Chile.

The company received several unprotected applications with a proposal for binding expected by July 2025 for a unit, potentially estimated about $ 1 billion. This strategic initiative is aimed at improving the company’s attention in its main, more profitable US markets.

Such optimization can have a positive effect on general financial indicators.

Is the united group group trading at a discount?

Mid -April before the reeds in mid -May, in the price of shares, Unitedhealt Group brought its indicators in a clearer focus for investors.

The advanced ratio of the company’s profit (P/E), which compares its current price of shares with the expected profit per share over the next twelve months, From approximately 10.5 to 11Field

This rating indicator is noticeably lower than the historical group Unitedhealth Group 5-year average p/e.Which was usually varied in higher teenagers until the low twenties.

This lower p/e suggests that shares can be traded at a lower price compared to its past indicators, offering a convincing opportunity for capital assessment for long -term investors who recognize the main value of the company.

As a leadership leadership, the future of Unitedhealth

The leadership team Unitedhealt Group plays a key role in navigation for the difficulties of the health industry. The return of Stephen Hemley as the general director brings extensive preliminary stay (2006-2017). Its proven ability to direct the company through various industry cycles ensures a decisive element of stability during periods of dynamic changes.

Significant insider actions acquire even more emphasize this confidence from above. In mid -2025, Hemley himself invested about $ 25 million in the company’s shares. Financial Director John Rex acquired about $ 5 million. These significant personal obligations from the senior leaders signal the strong internal conviction in the strategic direction and the ability of the company to manage the developing dynamics of the industry.

Unitedhealth: A strong contender for long -term portfolios

Unitedhealt Group represents a convincing investment case. This is due to its recently enlarged dividends, strategic efforts to sell and an attractive assessment. All these factors are supported by his diversified business model and experimental guidance.

Since the leadership is actively focusing on the dynamics of the industry, the Unitedhealth Group remains well located for future growth. It offers a special opportunity for a long -term inclusion of a portfolio for investors striving for durability, growth and stability in the healthcare sector.

Before considering the Unitedhealth group, you will want to hear it.

Marketbeat monitors the highest and most effective analysts with the most effective Wall Street analysts and promotions that they recommend to their customers daily. Marketbeat has identified five shares that leading analysts quietly whisper to their clients to buy now before the wider market conquers … and Unitedhealt Group was not on the list.

While Unitedhealth Group currently has a moderate purchase rating among analysts, analysts with the highest rating believe that these five promotions are better buying.

View five shares here

Like this article? Share this with a colleague.

The link is copied to the exchange buffer.